Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 19 Tumor-Agnostic 2 Gynecologic 2 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1 Classical hematology 1

Conditions

Sarcoma 10 Sarcoma, Ewing 4 Liposarcoma 4 Rhabdomyosarcoma 3 Rhabdoid Tumor 3 Osteosarcoma 3 Neuroblastoma 3 Medulloblastoma 3 Glioma 3 Wilms Tumor 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Ependymoma 2 Chordoma 2 Breast Neoplasms 2 Xanthogranuloma, Juvenile 1 Urinary Bladder Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Liposarcoma, Myxoid 1 Histiocytic Sarcoma 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioblastoma 1

Interventions

pembrolizumab 11 Gemcitabine 10 Doxorubicin 10 Cyclophosphamide 9 Specimen Handling 8 Nivolumab 8 Ibandronic Acid 8 pazopanib 7 Radiosurgery 6 Magnetic Resonance Spectroscopy 6 Imatinib Mesylate 6 Biopsy 6 Bevacizumab 6 Irinotecan 5 regorafenib 4 Zoledronic Acid 4 Ipilimumab 4 Ifosfamide 4 Fluorouracil 4 Docetaxel 4 Cetuximab 4 sargramostim 3 conatumumab 3 cemiplimab 3 Sunitinib 3 Radiation 3 Paclitaxel 3 Leucovorin 3 Cryosurgery 3 Cisplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × palbociclib × Sarcoma × Clear all

NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡